首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引37754条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xiaoyu Yang,Xiaofeng Chen,Yi Zhang et al. Xiaoyu Yang et al.
Background: Angiomatoid fibrous histiocytoma (AFH) is a rare tumor typically arising in the extremities or trunk. Its intracranial occurrence in young infants constitutes a distinct rarity that poses significant clinical ...
Hongxia Wang,Yijie Li,Zhifen Yang et al. Hongxia Wang et al.
Objective: To analyze the surgical treatment and prognosis of patients with advanced epithelial ovarian cancer with intestinal metastases. Methods: ...
Hanna Veronika Salvotti,Francesco Brigo,Paolo Cipriano Cecchi et al. Hanna Veronika Salvotti et al.
Introduction: Oligodendrogliomas (ODGs) are IDH-mutated gliomas with 1p/19q co-deletion, typically associated with better outcomes than astrocytomas. Symptomatic leptomeningeal dissemination (LMD) is exceptionally rare, a...
Jiaying Yu,Yanyu Qin,Yunyun Zhu et al. Jiaying Yu et al.
Purpose: To investigate the impact of adrenal metastases (AM) of differentiated thyroid cancer (DTC) through the comparison of clinicopathological characteristics and prognoses between DTC patients with AM and those with ...
Xiaofeng Mei,Mengqin Zhao,Yi Li et al. Xiaofeng Mei et al.
Background: Implant-based breast reconstruction demonstrates notable psychological benefits, particularly in enhancing postoperative emotional well-being and self-perception among breast cancer survivors. However, its per...
Haochun Tang,Ziying Li,Ziyuan Zhou et al. Haochun Tang et al.
Trastuzumab deruxtecan is a life-saving but costly therapy for HER2-positive cancers. While dose rounding strategies have been proposed to reduce drug waste, their safety and cost-saving potential in real-world Chinese patients remain under...
Jiangzhuo Wu,Hanbing Li,Ling Wei et al. Jiangzhuo Wu et al.
Clinical trial registration: Globally, breast cancer is the most common malignancy in women. Despite treatment advances, 20-30% of early-stage patients progress to advanced disease, which remains largely incurable with a ...
Yuanhong Liu,Suzheng Zheng,Hao Song et al. Yuanhong Liu et al.
Background: Cutaneous squamous cell carcinoma (cSCC) carries a risk of postoperative local recurrence, with nearly 90% of events occurring within 3 years; however, prognostic tools tailored to Asian populations remain lim...
Jiaxi Yao,Zhifei Xie,Guangyao Shi et al. Jiaxi Yao et al.
Background: Anaplastic lymphoma kinase (ALK)-rearranged renal cell carcinoma (ALK-RCC) is a rare provisional entity characterized by fusion of the ALK gene with various fusion partner genes, resulting in oncogenic activat...